We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note
Read MoreHide Full Article
Doximity (DOCS - Free Report) closed the most recent trading day at $25.81, moving -2.2% from the previous trading session. The stock's change was less than the S&P 500's daily loss of 0.45%. Meanwhile, the Dow lost 0.63%, and the Nasdaq, a tech-heavy index, lost 0.78%.
Coming into today, shares of the medical social networking site had gained 7.63% in the past month. In that same time, the Medical sector gained 0.57%, while the S&P 500 lost 1.99%.
Analysts and investors alike will be keeping a close eye on the performance of Doximity in its upcoming earnings disclosure. The company is predicted to post an EPS of $0.34, indicating a 24.44% decline compared to the equivalent quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $170.66 million, up 1.27% from the prior-year quarter.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $1.33 per share and a revenue of $675.74 million, signifying shifts of -12.5% and +4.79%, respectively, from the last year.
Investors should also take note of any recent adjustments to analyst estimates for Doximity. These recent revisions tend to reflect the evolving nature of short-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. As of now, Doximity holds a Zacks Rank of #3 (Hold).
Investors should also note Doximity's current valuation metrics, including its Forward P/E ratio of 19.78. This indicates a discount in contrast to its industry's Forward P/E of 28.27.
Investors should also note that DOCS has a PEG ratio of 11.5 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As the market closed yesterday, the Medical Info Systems industry was having an average PEG ratio of 3.24.
The Medical Info Systems industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 85, placing it within the top 35% of over 250 industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
View the Zacks #1 Rank List
Image: Bigstock
Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note
Doximity (DOCS - Free Report) closed the most recent trading day at $25.81, moving -2.2% from the previous trading session. The stock's change was less than the S&P 500's daily loss of 0.45%. Meanwhile, the Dow lost 0.63%, and the Nasdaq, a tech-heavy index, lost 0.78%.
Coming into today, shares of the medical social networking site had gained 7.63% in the past month. In that same time, the Medical sector gained 0.57%, while the S&P 500 lost 1.99%.
Analysts and investors alike will be keeping a close eye on the performance of Doximity in its upcoming earnings disclosure. The company is predicted to post an EPS of $0.34, indicating a 24.44% decline compared to the equivalent quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $170.66 million, up 1.27% from the prior-year quarter.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $1.33 per share and a revenue of $675.74 million, signifying shifts of -12.5% and +4.79%, respectively, from the last year.
Investors should also take note of any recent adjustments to analyst estimates for Doximity. These recent revisions tend to reflect the evolving nature of short-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. As of now, Doximity holds a Zacks Rank of #3 (Hold).
Investors should also note Doximity's current valuation metrics, including its Forward P/E ratio of 19.78. This indicates a discount in contrast to its industry's Forward P/E of 28.27.
Investors should also note that DOCS has a PEG ratio of 11.5 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As the market closed yesterday, the Medical Info Systems industry was having an average PEG ratio of 3.24.
The Medical Info Systems industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 85, placing it within the top 35% of over 250 industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.